The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems.
from MobiHealthNews http://ift.tt/2BZOJqr
February 06, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Avizia to demo connectivity-focused telehealth module at HIMSS18Telehealth technologies can connect patients and providers across miles, but some wrinkles still persist. Healthcare systems’ telemedicine devices often come in a slew of different makes and models, and a physician’s standard… Read More
Zipnosis moves telemedicine away from video, toward providersMinneapolis, Minnesota-based Zipnosis is bucking traditional telemedicine wisdom in two ways. One, the company has always worked to deliver telemedicine services to patients by working with their existing provider. Two, they … Read More
Orbita's AI, voice tech supports Pillo's home robot and other digital health dealsPillo Health has announced a deal with AI and voice assistant company Orbita to power the former’s in-home medication adherence robot. The partnership will allow the Pillo platform, set to debut at HIMSS 2018, to better assis… Read More
Samsung's Galaxy S9 to include blood pressure monitor, research appSamsung’s latest phones, the Galaxy S9 and S9+, will incorporate a new digital health app that will track users' blood pressure and stress level while helping researchers collect data. Seoul-based Samsung Electronics teamed u… Read More
In-Depth: Cryptocurrency's digital health potential for data sharing, behavior incentivesAs Bitcoin and other cryptocurrencies take off in a gold rush-like fashion, players in the digital health field have jumped on board the cryptocurrency wagon. Some companies, like Nobel Prize contender George Church’s brainch… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment